MVA Vector for COVID-19 VLP Vaccine development
In stock
Price $100 (USD)
Type New
The number of patients with SARS-CoV-2 pneumonia in the world has exceeded 10 million, and accelerating the development of vaccine products will become a key way to solve this global disaster. With mature and well-established vaccine development system, Creative Biolabs has several vaccine-related platforms, which can provide complete vaccine development and evaluation services to overcome COVID-19. MVA Vector for COVID-19 VLP Vaccine development https://sars-cov-2.creative-bi....olabs.com/sars-cov-2
Like
Comment
Share
